Home
NUVL
NUVL News

Latest Nuvalent Inc. (NUVL) News on December 18, 2024

Nuvalent Appoints Grant Bogle to Board of Directors

PR Newswire

9 days ago

Nuvalent Appoints Grant Bogle to Board of Directors

Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference

PR Newswire

22 days ago

Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference

MT Newswires

a month ago

Nuvalent's Q3 Net Loss Widens

Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results

PR Newswire

a month ago

Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results

MT Newswires

a month ago

Nuvalent Insider Sold Shares Worth $442,980, According to a Recent SEC Filing

MT Newswires

2 months ago

UBS Initiates Nuvalent With Neutral Rating, $100 Price Target

MT Newswires

3 months ago

Nuvalent Insider Sold Shares Worth $508,718, According to a Recent SEC Filing

Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates

Zacks

3 months ago

Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates

MT Newswires

3 months ago

Nuvalent Insider Sold Shares Worth $3,244,140, According to a Recent SEC Filing

MT Newswires

3 months ago

Nuvalent Raises $575 Million From Share Offering

Nuvalent Announces Closing of Upsized Public Offering of Common Stock

PR Newswire

3 months ago

Nuvalent Announces Closing of Upsized Public Offering of Common Stock

Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally?

Zacks

3 months ago

Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally?

Company News for Sep 17, 2024

Zacks

3 months ago

Company News for Sep 17, 2024

MT Newswires

3 months ago

Nuvalent Prices $500 Million Stock Offering

Nuvalent Announces Pricing of Upsized Public Offering of Common Stock

PR Newswire

3 months ago

Nuvalent Announces Pricing of Upsized Public Offering of Common Stock

Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths

Investor's Business Daily

3 months ago

Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths

MT Newswires

3 months ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

3 months ago

Top Midday Gainers

MT Newswires

3 months ago

Update: Nuvalent Shares Jump After Trials of Lung Cancer Drugs Show 'Favorable Tolerability'

Cancer Biotech Nuvalent’s Stock Jumps on Positive Data

Barrons.com

3 months ago

Cancer Biotech Nuvalent’s Stock Jumps on Positive Data

MT Newswires

3 months ago

Nuvalent Says 2 Potential Lung Cancer Drugs Show 'Favorable Tolerability'

MT Newswires

3 months ago

Sector Update: Health Care Stocks Flat to Higher Premarket Monday

MT Newswires

3 months ago

Sector Update: Health Care

MT Newswires

3 months ago

Nuvalent Launches $350 Million Common Stock Offering

MT Newswires

3 months ago

Wedbush Raises Price Target on Nuvalent to $115 From $99, Keeps Outperform Rating

Nuvalent Announces Public Offering of Common Stock

PR Newswire

3 months ago

Nuvalent Announces Public Offering of Common Stock

Nuvalent, Inc. (NUVL): Among Hedge Funds’ Top Biotech Stock Picks

Insider Monkey

3 months ago

Nuvalent, Inc. (NUVL): Among Hedge Funds’ Top Biotech Stock Picks

Nuvalent, Inc. (NUVL): Short Seller Sentiment is Bearish on This Cancer Stock

Insider Monkey

3 months ago

Nuvalent, Inc. (NUVL): Short Seller Sentiment is Bearish on This Cancer Stock

Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines

PR Newswire

3 months ago

Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines

Nuvalent Announces Publication in Cancer Discovery Detailing Design and Characterization of ALK-selective inhibitor NVL-655

PR Newswire

3 months ago

Nuvalent Announces Publication in Cancer Discovery Detailing Design and Characterization of ALK-selective inhibitor NVL-655

Updated Data for Nuvalent's ALK-Selective Inhibitor, NVL-655, and ROS1-Selective Inhibitor, Zidesamtinib, Continue to Support Potential Best-in-Class Profiles

PR Newswire

3 months ago

Updated Data for Nuvalent's ALK-Selective Inhibitor, NVL-655, and ROS1-Selective Inhibitor, Zidesamtinib, Continue to Support Potential Best-in-Class Profiles

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Simply Wall St.

4 months ago

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Nuvalent to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

PR Newswire

4 months ago

Nuvalent to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

MT Newswires

4 months ago

Barclays Initiates Nuvalent at Overweight

MT Newswires

4 months ago

Nuvalent Insider Sold Shares Worth $935,440, According to a Recent SEC Filing

MT Newswires

4 months ago

Nuvalent Insider Sold Shares Worth $893,340, According to a Recent SEC Filing

MT Newswires

4 months ago

Nuvalent's Q2 Net Loss Widens

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2024 Financial Results

PR Newswire

4 months ago

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2024 Financial Results

MT Newswires

5 months ago

Nuvalent Insider Sold Shares Worth $795,074, According to a Recent SEC Filing

Nuvalent doses first subject in Phase Ia/Ib trial of lung cancer treatment

Clinical Trials Arena

5 months ago

Nuvalent doses first subject in Phase Ia/Ib trial of lung cancer treatment

Nuvalent Announces First Patient Dosed in HEROEX-1 Phase 1a/1b Clinical Trial of NVL-330, its Novel HER2-selective Inhibitor

PR Newswire

5 months ago

Nuvalent Announces First Patient Dosed in HEROEX-1 Phase 1a/1b Clinical Trial of NVL-330, its Novel HER2-selective Inhibitor

MT Newswires

5 months ago

Nuvalent Insider Sold Shares Worth $403,621, According to a Recent SEC Filing

Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Zidesamtinib, and ALK-Selective Inhibitor, NVL-655, at the ESMO Congress 2024

PR Newswire

5 months ago

Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Zidesamtinib, and ALK-Selective Inhibitor, NVL-655, at the ESMO Congress 2024

MT Newswires

5 months ago

Nuvalent Names Henry Pelish Chief Scientific Officer; Shares Rise

Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer

PR Newswire

5 months ago

Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer

MT Newswires

5 months ago

Stifel Adjusts Price Target on Nuvalent to $115 From $103, Maintains Buy Rating

MT Newswires

6 months ago

Nuvalent Insider Sold Shares Worth $643,213, According to a Recent SEC Filing

Nuvalent to Participate in the 2024 Jefferies Global Healthcare Conference

PR Newswire

7 months ago

Nuvalent to Participate in the 2024 Jefferies Global Healthcare Conference

MT Newswires

7 months ago

Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing

FDA grants breakthrough therapy status for Nuvalent’s NVL-655

Pharmaceutical Technology

7 months ago

FDA grants breakthrough therapy status for Nuvalent’s NVL-655

MT Newswires

7 months ago

Nuvalent Gets Breakthrough Therapy Designation for Lung Cancer Treatment Candidate

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655

PR Newswire

7 months ago

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655

MT Newswires

7 months ago

Nuvalent Q1 Net Loss Widens

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results

PR Newswire

7 months ago

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results

MT Newswires

7 months ago

Nuvalent Insider Sold Shares Worth $2,605,525, According to a Recent SEC Filing

Why Earnings Season Could Be Great for Nuvalent (NUVL)

Zacks

7 months ago

Why Earnings Season Could Be Great for Nuvalent (NUVL)

MT Newswires

8 months ago

Nuvalent Insider Sold Shares Worth $2,666,555, According to a Recent SEC Filing

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024

PR Newswire

8 months ago

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024

Chief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)

GuruFocus.com

8 months ago

Chief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

Barrons.com

8 months ago

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL)

GuruFocus.com

9 months ago

Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL)

Chief Development Officer Darlene Noci Sells 20,000 Shares of Nuvalent Inc (NUVL)

GuruFocus.com

9 months ago

Chief Development Officer Darlene Noci Sells 20,000 Shares of Nuvalent Inc (NUVL)

Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth

Simply Wall St.

9 months ago

Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth

Director Emily Conley Sells 13,333 Shares of Nuvalent Inc (NUVL)

GuruFocus.com

9 months ago

Director Emily Conley Sells 13,333 Shares of Nuvalent Inc (NUVL)

Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024

PR Newswire

9 months ago

Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024

GuruFocus.com

10 months ago

Nuvalent Inc (NUVL) Reports Full Year and Q4 2023 Financial Results with Strong Cash Position ...

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire

10 months ago

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520

PR Newswire

10 months ago

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520

13 Best Short Squeeze Stocks To Buy Now

Insider Monkey

10 months ago

13 Best Short Squeeze Stocks To Buy Now

Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid Tumors

PR Newswire

10 months ago

Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid Tumors

These Stocks Are Moving the Most Today

Barrons.com

a year ago

These Stocks Are Moving the Most Today

Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

PR Newswire

a year ago

Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Thomson Reuters StreetEvents

a year ago

Q4 2023 Littelfuse Inc Earnings Call

Morningstar Research

a year ago

Analyst Report: Littelfuse, Inc.

Littelfuse (LFUS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

a year ago

Littelfuse (LFUS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

Motley Fool

a year ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

GlobeNewswire

a year ago

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education

PR Newswire

a year ago

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education

Zacks Value Trader Highlights: Dell Technologies, International Business Machines, Silicon Motion Technology, Zoom Video Communications and NetApp

Zacks

a year ago

Zacks Value Trader Highlights: Dell Technologies, International Business Machines, Silicon Motion Technology, Zoom Video Communications and NetApp

Is Zoom Video A Buy Amid Artificial Intelligence Software Race?

Investor's Business Daily

a year ago

Is Zoom Video A Buy Amid Artificial Intelligence Software Race?

5 Relative Price Strength Stocks Compelling Enough to Buy

Zacks

a year ago

5 Relative Price Strength Stocks Compelling Enough to Buy

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks

StockStory

a year ago

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks

Old Republic International Corporation (NYSE:ORI) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Old Republic International Corporation (NYSE:ORI) Q4 2023 Earnings Call Transcript

Berkshire Bought More Liberty Sirius Tracking Stock. Behind the Big Bet That Seems Almost Too Easy.

Barrons.com

a year ago

Berkshire Bought More Liberty Sirius Tracking Stock. Behind the Big Bet That Seems Almost Too Easy.

With A 13% Return On Equity, Is International Game Technology PLC (NYSE:IGT) A Quality Stock?

Simply Wall St.

a year ago

With A 13% Return On Equity, Is International Game Technology PLC (NYSE:IGT) A Quality Stock?

Warren Buffett Bolsters Holdings in Liberty SiriusXM Group

GuruFocus.com

a year ago

Warren Buffett Bolsters Holdings in Liberty SiriusXM Group

Weyerhaeuser (WY) Surpasses Q4 Earnings Estimates

Zacks

a year ago

Weyerhaeuser (WY) Surpasses Q4 Earnings Estimates

Dun & Bradstreet Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call; Participation in Upcoming Investor Conferences

Business Wire

a year ago

Dun & Bradstreet Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call; Participation in Upcoming Investor Conferences

CGI and National Bank of Canada sign long-term service agreement

CNW Group

a year ago

CGI and National Bank of Canada sign long-term service agreement

Here's What Key Metrics Tell Us About Hexcel (HXL) Q4 Earnings

Zacks

a year ago

Here's What Key Metrics Tell Us About Hexcel (HXL) Q4 Earnings

Here's What to Expect From Eagle Materials' (EXP) Q3 Earnings

Zacks

a year ago

Here's What to Expect From Eagle Materials' (EXP) Q3 Earnings

Webster Financial (WBS) Dips 2.3% Despite In-Line Q4 Earnings

Zacks

a year ago

Webster Financial (WBS) Dips 2.3% Despite In-Line Q4 Earnings

5 Low Leverage Stocks to Buy on Expectations of Rate Cuts

Zacks

a year ago

5 Low Leverage Stocks to Buy on Expectations of Rate Cuts

Here's Why You Should Retain Globus Medical (GMED) Stock Now

Zacks

a year ago

Here's Why You Should Retain Globus Medical (GMED) Stock Now

Vehicle Retailer Stocks Q3 Teardown: CarMax (NYSE:KMX) Vs The Rest

StockStory

a year ago

Vehicle Retailer Stocks Q3 Teardown: CarMax (NYSE:KMX) Vs The Rest

Installed Building (IBP) Up 67% in 3 Months: Will It Sustain?

Zacks

a year ago

Installed Building (IBP) Up 67% in 3 Months: Will It Sustain?

Salesforce's $75 Million Bet On Its 'Favorite Day' Starts Paying Off

Investor's Business Daily

a year ago

Salesforce's $75 Million Bet On Its 'Favorite Day' Starts Paying Off

Activist Investors Are Acting Up

Motley Fool

a year ago

Activist Investors Are Acting Up

Nexstar Broadcasting Group (NXST) Suffers a Larger Drop Than the General Market: Key Insights

Zacks

a year ago

Nexstar Broadcasting Group (NXST) Suffers a Larger Drop Than the General Market: Key Insights

E&C Sector in Focus; KeyBanc Suggests 2 ‘Strong Buy’ Stocks

TipRanks

a year ago

E&C Sector in Focus; KeyBanc Suggests 2 ‘Strong Buy’ Stocks

Share on Social Networks: